Daniel Alexander QC acted for GSK in a claim to revoke Genentech’s patent relating to the use of anti-CD20 antibodies for RA therapy. Genentech applied to stay the
Daniel Alexander QC acted for GSK in a claim to revoke Genentech’s patent relating to the use of anti-CD20 antibodies for RA therapy. Genentech applied to stay the
8 New Square Intellectual Property. Lincoln’s Inn, London, WC2A 3QP.